The Fine Art of Administering a Tuberculin Skin Test
When administered correctly, the Mantoux test can be an invaluable tool for the detection of tuberculosis.
Tuberculosis
TUBERCULOSIS
FEATURED
LATEST FEATURES
Whole Genome Sequencing Use in Predicting TB Resistance
Whole genome sequencing of M tuberculosis isolates can identify complete drug susceptibility profiles, allowing precise treatment in early TB infection.
Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?
The Lancet Respiratory Medicine staged a debate between proponents and opponents of pan-TB regimens to tackle the current suboptimal worldwide management of TB resistance.
Latent Tuberculosis Testing and Treatment Recommendations
Recommendations for testing and treating latent TB infection have been discussed by a representative from the California Department of Public Health.
LATEST NEWS
Post-Tuberculosis Lung Disease in HIV-Associated Tuberculosis Common
Post-tuberculosis lung disease is common in patients with HIV-associated tuberculosis at high risk for tuberculosis-associated immune reconstitution inflammatory syndrome.
Tuberculosis Pleural Effusion Diagnosis: Accuracy of Genotype Line Probe Assay
Despite having a good specificity for tuberculous pleural effusion diagnosis, genotype MTBDRplus line probe assay could not be included in most diagnostic algorithms as a result of its low sensitivity.
Inclusion of Noncountable Tuberculosis Cases Key to Estimate Regional Financial Burden
Reporting of all verified TB cases, countable and noncountable, to the National Tuberculosis Surveillance System is necessary for capturing the true burden of TB and providing high-quality data for TB surveillance.
Tuberculosis Prevention Should Be Delayed Until After Pregnancy in Women With HIV
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
Multidrug-Resistant Tuberculosis: New Clinical Practice Guideline
Use of at least 5 drugs recommended for intensive-phase treatment and 4 drugs for continuation phase.
M72/AS01 Tuberculosis Vaccine Remains Efficacious After 3 Years
The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years in patients with Mycobacterium tuberculosis infection.
Tuberculosis Vaccine Associated With Lower Lung Cancer Rates
In a 60-year follow-up, significantly lower lung cancer rates seen among people with childhood BCG vaccination.
Gout Risk During Tuberculosis Treatment Higher With Obesity, CKD, Hyperuricemia
Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.
Want to read more?
Please login or register first to view this content.
Next post in Tuberculosis
